IL108587A - שיטות וערכה לאיבחון סכרת ומצבים טרום-סכרתיים - Google Patents

שיטות וערכה לאיבחון סכרת ומצבים טרום-סכרתיים

Info

Publication number
IL108587A
IL108587A IL108587A IL10858794A IL108587A IL 108587 A IL108587 A IL 108587A IL 108587 A IL108587 A IL 108587A IL 10858794 A IL10858794 A IL 10858794A IL 108587 A IL108587 A IL 108587A
Authority
IL
Israel
Prior art keywords
gad
antigen
iddm
isoforms
serum
Prior art date
Application number
IL108587A
Other languages
English (en)
Other versions
IL108587A0 (en
Original Assignee
Univ Monash
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Monash filed Critical Univ Monash
Publication of IL108587A0 publication Critical patent/IL108587A0/xx
Publication of IL108587A publication Critical patent/IL108587A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
IL108587A 1993-02-09 1994-02-08 שיטות וערכה לאיבחון סכרת ומצבים טרום-סכרתיים IL108587A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL716893 1993-02-09

Publications (2)

Publication Number Publication Date
IL108587A0 IL108587A0 (en) 1994-05-30
IL108587A true IL108587A (he) 1998-01-04

Family

ID=3776693

Family Applications (1)

Application Number Title Priority Date Filing Date
IL108587A IL108587A (he) 1993-02-09 1994-02-08 שיטות וערכה לאיבחון סכרת ומצבים טרום-סכרתיים

Country Status (12)

Country Link
US (1) US5770381A (he)
EP (1) EP0686262B1 (he)
JP (1) JP3510889B2 (he)
AT (1) ATE229650T1 (he)
CA (1) CA2155677A1 (he)
DE (1) DE69431874D1 (he)
IL (1) IL108587A (he)
NZ (1) NZ261541A (he)
SG (1) SG45161A1 (he)
TW (1) TW305936B (he)
WO (1) WO1994018568A1 (he)
ZA (1) ZA94845B (he)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821334A (en) * 1996-01-26 1998-10-13 Vanderbilt University Insulin-dependent diabetes mellitus-specific chimeric polypeptides
FR2759701B1 (fr) * 1997-02-19 1999-06-04 Inst Nat Sante Rech Med Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
WO2000073800A1 (en) * 1999-06-01 2000-12-07 Kyokuto Pharmaceutical Industrial Co., Ltd. Method for assaying anti-gad antibody and kit
ES2684976T3 (es) 2012-04-13 2018-10-05 Diabetomics, Inc. Biomarcadores maternos para diabetes gestacional

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682906B1 (en) * 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
CA2104225C (en) * 1991-02-22 2001-07-17 Leonard Harrison Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
WO1992019972A1 (en) * 1991-05-03 1992-11-12 Novo Nordisk A/S Islet cell autoantigen (gad) for the detection of preclinical diabetes

Also Published As

Publication number Publication date
WO1994018568A1 (en) 1994-08-18
ATE229650T1 (de) 2002-12-15
CA2155677A1 (en) 1994-08-18
NZ261541A (en) 1996-09-25
US5770381A (en) 1998-06-23
EP0686262A4 (en) 1997-06-04
TW305936B (he) 1997-05-21
IL108587A0 (en) 1994-05-30
DE69431874D1 (de) 2003-01-23
JP3510889B2 (ja) 2004-03-29
JPH08506417A (ja) 1996-07-09
ZA94845B (en) 1994-11-11
SG45161A1 (en) 1998-01-16
EP0686262A1 (en) 1995-12-13
EP0686262B1 (en) 2002-12-11

Similar Documents

Publication Publication Date Title
Rowley et al. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus
Hawa et al. Value of Antibodies to Islet Protein Tyrosine Phosphatase–Like Molecule in Predicting Type 1 Diabetes
CA2040555C (en) Cloned glutamic acid decarboxylase
Pietropaolo et al. Combined analysis of GAD65 and ICA512 (IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus
Arif et al. Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease
US7718386B1 (en) Methods for the diagnosis of diabetes
Ozawa et al. Detection of autoantibodies to the pancreatic islet heat shock protein 60 in insulin-dependent diabetes mellitus
US5512447A (en) Methods for the diagnosis and treatment of diabetes
Zimmet et al. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender
US5770381A (en) Methods for the diagnosis of diabetes and prediabetic conditions
Yu et al. Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type I diabetes
Kulmala et al. Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren
Gianani et al. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA DQB1* 0602 allele
US5674692A (en) Methods for diabetes susceptibility assessment in asymptomatic patients
EP0693183B1 (en) Methods for diabetes susceptibility assessment in asymptomatic patients
AU688304B2 (en) Methods for the diagnosis of diabetes and prediabetic conditions
US5407802A (en) Method of accessing the risks of developing type I diabetes
Ziegler et al. Autoantibodies to glutamate decarboxylase detected in diabetes-prone BB/OK rats do not distinguish onset of diabetes
McEvoy et al. Anti-islet autoantibodies detected by monoclonal antibody 1A2: further studies suggesting a role in the pathogenesis of IDDM
Rowley et al. Diabetic sera react with the glutamic acid decarboxylase molecule in a dimeric‐oligomeric form
Gut et al. Recombinant human thyroid peroxidase produced in insect cells has similar properties to native human thyroid peroxidase
Ng et al. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus
Scherbaum Cytoplasmic islet cell antibodies (ICA): towards a molecular understanding of the autoantigens
Guazzarotti et al. Reactivity of islet cell antibodies (ICA) to recombinant glutamic acid decarboxylase (GAD)
Smith Thyroid Peroxidase

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force